Physicians' Academy for Cardiovascular Education
Preventing cardiovascular disease in patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practice

Preventing cardiovascular disease in patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practice

CME accredited E-Learning

Online-CME - Online-CME - This course consists of 3 separate lectures

This CME accredited course consists of 3 separate short (12 - 15 minute) lectures. View and complete all 3 items separately and earn 1 CME credit

In this educational programme the role of GLP-1 receptor agonists in preventing cardiovascular disease in patients with T2DM will be discussed

This course consists of the following 3 lectures

Educational objectives of this course are to:

Expert faculty

Target audience

This educational activity is designed for cardiologists in preventive cardiology and other healthcare professionals with an interest in treating patients with cardiovascular disease

CME accreditation

This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s).

Funding

Supported by an unrestricted educational grants received from Novo Nordisk

Online-CME

This is available as accredited online CME for members. Click the button below to enroll:

Enroll
Preventing cardiovascular disease in patients with T2DM: How to apply novel outcome data with GLP-1 RA to clinical practice

Share this page with your colleagues and friends: